Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://endpts.com/agc-to-use-recently-expanded-germany-site-for-peanut-allergy-drug-trials/
https://www.agcbio.com/news/allergy-therapeutics-selects-agc-biologics-to-manufacture-novel-peanut-allergy-vaccine-candidate
https://www.globenewswire.com/news-release/2022/01/26/2373343/0/en/Allergy-Therapeutics-announces-FDA-clearance-of-IND-application-for-novel-peanut-allergy-vaccine-candidate-VLP-Peanut.html
https://www.investegate.co.uk/allergy-therapeutics--agy-/rns/secondary-endpoints-from-vlp-peanut-001/202109130700074838L/
https://www.investegate.co.uk/allergy-therapeutics--agy-/rns/successful-primary-outcome-of-vlp-peanut-001/202108030700073254H/
https://www.directorstalkinterviews.com/allergy-therapeutics-announces-completion-of-treatment-phase-in-innovative-g309-exploratory-field-study/412985692
https://pipelinereview.com/index.php/2020102676286/Vaccines/Allergy-Therapeutics-announces-start-of-innovative-exploratory-field-study-to-evaluate-efficacy-and-safety-of-Grass-MATA-MPL.html#:~:text=Grass%20MATA%20MPL-,Allergy%20Therapeutics%20announces%20start%20of%20innovative%20exploratory%20field%20study%20to,safety%20of%20Grass%20MATA%20MPL&text=Grass%20MATA%20MPL%20is%20a,rhinoconjunctivitis%20due%20to%20grass%20pollen.
https://www.investegate.co.uk/allergy-therapeutics--agy-/rns/invalidation-of-birch-mata-mpl-phase-iii-results/202007090700064647S/
https://www.globenewswire.com/news-release/2019/06/27/1875464/0/en/Allergy-Therapeutics-plc-Successful-litigation-settlement-relating-to-PQ-Grass-Phase-II-Trial.html
http://www.pharmatimes.com/news/positive_phase_i_results_for_allergys_acarovac_1288840